Valuation Mega Lifesciences Thailand S.E.

Stocks

End-of-day quote Thailand S.E. 2026-08-19			5-day change	1st Jan Change
36.50 ^THB	-2.67%		-5.19%	+8.96%

08-12	Mega Lifesciences Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-15	Mega Lifesciences Public Company Limited, Q1 2026 Earnings Call, May 14, 2026

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	44,029	40,760	35,093	28,990	29,208	31,823	-	-
Change	-	-7.43%	-13.9%	-17.39%	0.75%	8.96%	-	-
Enterprise Value (EV) ¹	41,666	38,309	32,456	25,464	25,051	27,207	27,103	26,770
Change	-	-8.06%	-15.28%	-21.54%	-1.62%	8.6%	-0.38%	-1.23%
P/E	22.6x	18.2x	17.6x	14.4x	15.3x	13.5x	12.8x	12x
PBR	5.5x	4.64x	3.77x	2.94x	2.86x	2.99x	2.87x	2.76x
PEG	-	1.2x	-1.6x	16.49x	-2.95x	0.6x	2.45x	1.81x
Capitalization / Revenue	3.08x	2.6x	2.24x	1.89x	2.06x	2.22x	2.03x	1.93x
EV / Revenue	2.91x	2.44x	2.07x	1.66x	1.77x	1.9x	1.73x	1.63x
EV / EBITDA	17.2x	13x	10.2x	6.78x	8.73x	8.64x	7.68x	7.13x
EV / EBIT	18.1x	14.3x	11.2x	7.56x	9.69x	9.9x	8.52x	7.91x
EV / FCF	16.2x	22.6x	19.6x	11.8x	11.9x	13.2x	12.4x	11.9x
FCF Yield	6.18%	4.42%	5.09%	8.46%	8.41%	7.58%	8.06%	8.42%
Dividend per Share ²	1.06	1.61	1.65	1.6	1.6	1.76	1.897	2.021
Rate of return	2.1%	3.44%	4.1%	4.81%	4.78%	4.82%	5.2%	5.54%
EPS ²	2.23	2.57	2.29	2.31	2.19	2.71	2.851	3.04
Distribution rate	47.5%	62.6%	72.1%	69.3%	73.1%	64.9%	66.5%	66.5%
Net sales ¹	14,301	15,686	15,681	15,344	14,147	14,347	15,664	16,457
EBITDA ¹	2,426	2,953	3,190	3,756	2,868	3,150	3,529	3,756
EBIT ¹	2,305	2,681	2,904	3,370	2,585	2,748	3,180	3,383
Net income ¹	1,947	2,242	1,993	2,012	1,912	2,231	2,485	2,652
Net Debt ¹	-2,363	-2,451	-2,636	-3,525	-4,156	-4,617	-4,720	-5,053
Reference price ²	50.50	46.75	40.25	33.25	33.50	36.50	36.50	36.50
Nbr of stocks (in thousands)	871,870	871,870	871,870	871,870	871,870	871,870	-	-
Announcement Date	2/23/22	2/25/23	2/22/24	2/24/25	2/24/26	-	-	-

¹THB in Million²THB

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	35.07x	12.64x	25.79x	0.56%	1,093B
JOHNSON & JOHNSON	30.16x	-	-	1.98%	653B
ABBVIE INC.	33.05x	7.66x	15.93x	2.65%	458B
ROCHE HOLDING AG	20.11x	4.77x	11.83x	2.77%	355B
NOVARTIS AG	21.93x	5.66x	14.07x	2.83%	294B
ASTRAZENECA PLC	20.48x	4.23x	12x	2.08%	248B
AMGEN INC.	26.9x	6.98x	12.39x	2.37%	230B
NOVO NORDISK A/S	13.48x	4.8x	10.06x	3.81%	203B
GILEAD SCIENCES, INC.	-43.83x	6.34x	24.76x	2.3%	178B
Average	17.48x	6.63x	15.85x	2.37%	412.27B
Weighted average by Cap.	25.04x	8.32x	18.34x	1.93%